loading

Perché le azioni Lantheus Holdings Inc (LNTH) sono in ribasso?

Abbiamo notato un calo di 5.74% nelle azioni di Lantheus Holdings Inc (LNTH) durante la sessione di negoziazione di 2025-02-11. Sebbene ciò possa essere attribuito alla normale volatilità o a vari fattori interni ed esterni, tieni presente che stiamo monitorando attivamente la situazione e forniremo aggiornamenti tempestivi il prima possibile!
2023-12-18:

Shares of Lantheus Holdings Inc (LNTH) dropped by 26.88% from $76.04 to $55.60 in the trading on Monday, December 18, 2023. The reason why LNTH down today is due to the release of new data from a trial of the experimental prostate cancer treatment, Lu-PNT2002, developed by Lantheus Holdings and Point Biopharma Global Inc. The therapy achieved its primary goal with a median progression-free survival of 9.5 months, compared to six months for an alternative treatment. However, investors were disappointed as Novartis AG's Pluvicto, a similar radioligand therapy, showed better results with a median progression-free survival of 12 months in October.

$11.02
price down icon 0.99%
$35.32
price down icon 0.51%
$120.69
price up icon 3.94%
$11.25
price up icon 1.72%
$128.60
price up icon 0.05%
Capitalizzazione:     |  Volume (24 ore):